EUVIMEDEUVIMED entdecken
Open Access

A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection

Yuanyuan Qian, Biruk T Birhanu iD, Jingdong Yang iD, Derong Ding, Jeshina Janardhanan, Shahriar Mobashery iD, Mayland Chang iD

Journal of Medicinal Chemistry · 26.10.2023 · 66 (20) · 13891-13899

DOI: 10.1021/acs.jmedchem.3c01249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 21.09.2023. Verfasst von Yuanyuan Qian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Eck Institute for Global Health, University of Notre Dame.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile is an anaerobic Gram-positive bacterium that colonizes the gut of patients treated with broad-spectrum antibiotics. The normal gut microflora prevents C. difficile colonization; however, dysbiosis by treatment with broad-spectrum antibiotics causes recurrent C. difficile infection (CDI) in 25% of patients. There are no fully effective antibiotics for multiple recurrent CDIs. We report herein that oxadiazole antibiotics exhibit bactericidal activity against C. difficile vegetative cells. We screened a library of 75 oxadiazoles against C. difficile ATCC 43255. The findings from this collection served as the basis for the syntheses of an additional 58 analogs, which were tested against the same strain. We report a potent (MIC50 = 0.5 μg/mL and MIC90 = 1 μg/mL values for 101 C. difficile strains) and narrow-spectrum oxadiazole (3-(4-(cyclopentyloxy)phenyl)-5-(4-nitro-1H-imidazol-2-yl)-1,2,4-oxadiazole; compound 57), which is not active against common gut bacteria or other tested organisms. Compound 57 is selectively bactericidal against C. difficile and targets cell-wall synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsHumansAnti-Bacterial AgentsGram-Positive BacteriaOxadiazoles

Substanzen

Anti-Bacterial AgentsOxadiazoles

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

ORCID-Profile: Biruk T Birhanu, Jingdong Yang, Shahriar Mobashery, Mayland Chang

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Eck Institute for Global Health, University of Notre Dame

Zitieren

APA

Qian, Y., Birhanu, B. T., Yang, J., Ding, D., Janardhanan, J., Mobashery, S., & Chang, M. (2023). A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection. Journal of Medicinal Chemistry, 66(20), 13891-13899. https://doi.org/10.1021/acs.jmedchem.3c01249

Vancouver

Qian Y, Birhanu BT, Yang J, Ding D, Janardhanan J, Mobashery S, et al. A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection. Journal of Medicinal Chemistry. 2023;66(20):13891-13899. doi:10.1021/acs.jmedchem.3c01249

BibTeX
@article{Qian2023,
  author = {Qian, Yuanyuan and Birhanu, Biruk T and Yang, Jingdong and Ding, Derong and Janardhanan, Jeshina and Mobashery, Shahriar and Chang, Mayland},
  title = {A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {20},
  pages = {13891--13899},
  doi = {10.1021/acs.jmedchem.3c01249}
}
Kostenlos starten →